KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Goodwill (2018 - 2025)

Vir Biotechnology's Goodwill history spans 8 years, with the latest figure at $16.9 million for Q4 2025.

  • On a quarterly basis, Goodwill changed 0.22% to $16.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.9 million, a 0.22% change, with the full-year FY2025 number at $16.9 million, changed 0.22% from a year prior.
  • Goodwill hit $16.9 million in Q4 2025 for Vir Biotechnology, roughly flat from $16.9 million in the prior quarter.
  • Over the last five years, Goodwill for VIR hit a ceiling of $16.9 million in Q3 2024 and a floor of $16.9 million in Q4 2025.
  • Historically, Goodwill has averaged $16.9 million across 5 years, with a median of $16.9 million in 2021.
  • Biggest five-year swings in Goodwill: increased 0.01% in 2024 and later decreased 0.22% in 2025.
  • Tracing VIR's Goodwill over 5 years: stood at $16.9 million in 2021, then changed by 0.0% to $16.9 million in 2022, then changed by 0.0% to $16.9 million in 2023, then changed by 0.0% to $16.9 million in 2024, then dropped by 0.22% to $16.9 million in 2025.
  • Business Quant data shows Goodwill for VIR at $16.9 million in Q4 2025, $16.9 million in Q3 2025, and $16.9 million in Q2 2025.